|
DarioHealth Corp. (Drio) DCF Valoración
US | Healthcare | Medical - Diagnostics & Research | NASDAQ
|
- ✓ Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
- ✓ Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
- ✓ Predeterminadas Para Un Uso Rápido Y Eficiente
- ✓ No Se Necesita Experiencia; Fáciles De Seguir
DarioHealth Corp. (DRIO) Bundle
¡Mejore sus estrategias de inversión con la calculadora DCF de DarioHealth Corp. (DRIO)! Utilice datos financieros de DarioHealth reales, ajuste las predicciones y gastos de crecimiento, y observe instantáneamente cómo estos cambios influyen en el valor intrínseco de DarioHealth Corp. (DRIO).
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 7.6 | 7.6 | 20.5 | 27.7 | 20.4 | 25.9 | 32.9 | 41.8 | 53.2 | 67.7 |
| Revenue Growth, % | 0 | 0.2249 | 170.76 | 34.82 | -26.41 | 27.16 | 27.16 | 27.16 | 27.16 | 27.16 |
| EBITDA | -17.5 | -29.7 | -73.1 | -56.8 | -54.4 | -25.9 | -32.9 | -41.8 | -53.2 | -67.7 |
| EBITDA, % | -231.8 | -392.2 | -356.44 | -205.42 | -267.19 | -100 | -100 | -100 | -100 | -100 |
| Depreciation | .6 | .5 | 3.5 | 3.8 | 5.0 | 3.6 | 4.5 | 5.8 | 7.3 | 9.3 |
| Depreciation, % | 7.29 | 6.03 | 17.2 | 13.73 | 24.49 | 13.75 | 13.75 | 13.75 | 13.75 | 13.75 |
| EBIT | -18.1 | -30.2 | -76.6 | -60.6 | -59.4 | -25.9 | -32.9 | -41.8 | -53.2 | -67.7 |
| EBIT, % | -239.09 | -398.23 | -373.64 | -219.15 | -291.68 | -100 | -100 | -100 | -100 | -100 |
| Total Cash | 20.4 | 28.6 | 35.8 | 49.4 | 36.8 | 25.9 | 32.9 | 41.8 | 53.2 | 67.7 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | .7 | 1.7 | 1.8 | 6.4 | 3.6 | 4.2 | 5.4 | 6.8 | 8.7 | 11.1 |
| Account Receivables, % | 9.42 | 22.49 | 8.71 | 23.2 | 17.9 | 16.34 | 16.34 | 16.34 | 16.34 | 16.34 |
| Inventories | 1.4 | 2.3 | 6.2 | 8.0 | 5.1 | 6.9 | 8.8 | 11.1 | 14.2 | 18.0 |
| Inventories, % | 18.71 | 30.27 | 30.36 | 28.77 | 24.87 | 26.59 | 26.59 | 26.59 | 26.59 | 26.59 |
| Accounts Payable | 1.7 | 2.5 | 5.1 | 2.3 | 1.1 | 4.8 | 6.2 | 7.8 | 10.0 | 12.7 |
| Accounts Payable, % | 21.91 | 32.73 | 24.91 | 8.4 | 5.56 | 18.7 | 18.7 | 18.7 | 18.7 | 18.7 |
| Capital Expenditure | -.1 | -.1 | -.3 | -.6 | -.6 | -.5 | -.6 | -.8 | -1.0 | -1.2 |
| Capital Expenditure, % | -1.3 | -1.56 | -1.27 | -2.07 | -2.87 | -1.81 | -1.81 | -1.81 | -1.81 | -1.81 |
| Tax Rate, % | -0.10781 | -0.10781 | -0.10781 | -0.10781 | -0.10781 | -0.10781 | -0.10781 | -0.10781 | -0.10781 | -0.10781 |
| EBITAT | -18.1 | -29.7 | -76.7 | -60.6 | -59.4 | -25.8 | -32.8 | -41.7 | -53.0 | -67.5 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -18.1 | -30.4 | -74.8 | -66.5 | -50.6 | -21.4 | -30.6 | -38.9 | -49.4 | -62.9 |
| WACC, % | 6.66 | 6.62 | 6.66 | 6.66 | 6.66 | 6.65 | 6.65 | 6.65 | 6.65 | 6.65 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -162.8 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | -64 | |||||||||
| Terminal Value | -1,378 | |||||||||
| Present Terminal Value | -999 | |||||||||
| Enterprise Value | -1,162 | |||||||||
| Net Debt | -7 | |||||||||
| Equity Value | -1,154 | |||||||||
| Diluted Shares Outstanding, MM | 28 | |||||||||
| Equity Value Per Share | -40.69 |
What You Will Get
- Real DarioHealth Data: Preloaded financials – from revenue to EBIT – based on actual and projected figures.
- Full Customization: Adjust all critical parameters (yellow cells) like WACC, growth %, and tax rates.
- Instant Valuation Updates: Automatic recalculations to analyze the impact of changes on DarioHealth’s fair value.
- Versatile Excel Template: Tailored for quick edits, scenario testing, and detailed projections.
- Time-Saving and Accurate: Skip building models from scratch while maintaining precision and flexibility.
Key Features
- Comprehensive Historical Data: DarioHealth Corp.'s (DRIO) past financial statements and projected forecasts.
- Customizable Parameters: Adjust inputs like WACC, tax rates, revenue growth, and EBITDA margins to fit your analysis.
- Real-Time Insights: Instantly view DarioHealth Corp.'s (DRIO) intrinsic value as it updates live.
- Intuitive Visual Representations: Dashboard visuals showcase valuation outcomes and essential metrics.
- Designed for Precision: A robust tool tailored for analysts, investors, and finance professionals.
How It Works
- Download: Access the ready-to-use Excel file with DarioHealth Corp.'s (DRIO) financial data.
- Customize: Adjust forecasts, including revenue growth, EBITDA %, and WACC.
- Update Automatically: The intrinsic value and NPV calculations update in real-time.
- Test Scenarios: Create multiple projections and compare outcomes instantly.
- Make Decisions: Use the valuation results to guide your investment strategy.
Why Choose This Calculator for DarioHealth Corp. (DRIO)?
- Accurate Data: Utilizes the latest DarioHealth financials for dependable valuation insights.
- Customizable: Tailor essential parameters such as growth rates, WACC, and tax rates to fit your forecasts.
- Time-Saving: Built-in calculations save you the hassle of starting from scratch.
- Professional-Grade Tool: Crafted for investors, analysts, and consultants in the healthcare sector.
- User-Friendly: Easy-to-navigate design and clear instructions make it accessible for all users.
Who Should Use DarioHealth Corp. (DRIO)?
- Healthcare Investors: Develop comprehensive and accurate valuation models for evaluating investment opportunities.
- Corporate Strategy Teams: Assess valuation scenarios to inform business decisions and growth strategies.
- Financial Consultants: Deliver precise valuation insights for clients interested in DarioHealth Corp. (DRIO).
- Students and Educators: Utilize real-time data to enhance learning and practice in financial modeling.
- Health Tech Enthusiasts: Gain insights into the market valuation of innovative health technology companies like DarioHealth Corp. (DRIO).
What the Template Contains
- Pre-Filled DCF Model: DarioHealth Corp.'s (DRIO) financial data preloaded for immediate use.
- WACC Calculator: Detailed calculations for Weighted Average Cost of Capital tailored to DarioHealth.
- Financial Ratios: Assess DarioHealth's profitability, leverage, and efficiency metrics.
- Editable Inputs: Modify assumptions such as growth rates, margins, and CAPEX to suit your analysis.
- Financial Statements: Comprehensive annual and quarterly reports for in-depth evaluation.
- Interactive Dashboard: Effortlessly visualize key valuation metrics and results for DarioHealth Corp.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.